Review



picard sequencing metrics  (Broad Clinical Labs)


Bioz Verified Symbol Broad Clinical Labs is a verified supplier
Bioz Manufacturer Symbol Broad Clinical Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Broad Clinical Labs picard sequencing metrics
    a , Schematic workflow going from hiPS cells to cortical organoids to <t>sequencing</t> data. The number of hiPS cell lines and individuals (in parentheses) for each form of ASD and controls is indicated. b , Schematic representation of hCO differentiations derived from each hiPS cell line for two forms of ASD (16p11.2 deletion and 22q13.3 deletion). The other forms of ASD can be found in Extended Data Fig. . c , Spearman’s correlation of gene expression between samples from the same time point and form of ASD that were derived either from different lines (red) or from the same line (blue). The sample sizes for each group (number of differentiations) are as follows: day 25: control lines, n = 46; 15q13.3del, n = 7; 16p11.2del, n = 5; 16p11.2dup, n = 4; 22q11.2del, n = 13; 22q13.3del, n = 11; idiopathic, n = 12; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 3. Day 50: control lines, n = 53; 15q13.3del, n = 7; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 15; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19 , n = 2; SHANK3, n = 2; and Timothy syndrome, n = 3. Day 75: control lines, n = 54; 15q13.3del, n = 7; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 23; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 2. Day 100: control lines, n = 50; 15q13.3del, n = 6; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 15; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 2. Boxplots show: centre, median; lower hinge, 25% quantile; upper hinge, 75% quantile; lower whisker, smallest observation greater than or equal to lower hinge −1.5× interquartile range; upper whisker, largest observation less than or equal to upper hinge +1.5× interquartile range. d , Genes within the CNVs are downregulated in deletions and upregulated in duplications, as exemplified by 16p11.2 deletion (del) and duplication (dup) and 15q13.3 deletion. 16p11.2del, 61.5% of genes; 16p11.2dup, 50% of genes and 15q13.3del, 52.9% of genes. *dreamlet P values of less than 0.005. Top illustration adapted from ref. , Springer Nature America; illustrations in the IP–MS and CRISPRi panels created in BioRender. Geschwind, D. (2025) ( https://biorender.com/m2jkj03 ).
    Picard Sequencing Metrics, supplied by Broad Clinical Labs, used in various techniques. Bioz Stars score: 96/100, based on 711 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/picard sequencing metrics/product/Broad Clinical Labs
    Average 96 stars, based on 711 article reviews
    picard sequencing metrics - by Bioz Stars, 2026-05
    96/100 stars

    Images

    1) Product Images from "Developmental convergence and divergence in human stem cell models of autism"

    Article Title: Developmental convergence and divergence in human stem cell models of autism

    Journal: Nature

    doi: 10.1038/s41586-025-10047-5

    a , Schematic workflow going from hiPS cells to cortical organoids to sequencing data. The number of hiPS cell lines and individuals (in parentheses) for each form of ASD and controls is indicated. b , Schematic representation of hCO differentiations derived from each hiPS cell line for two forms of ASD (16p11.2 deletion and 22q13.3 deletion). The other forms of ASD can be found in Extended Data Fig. . c , Spearman’s correlation of gene expression between samples from the same time point and form of ASD that were derived either from different lines (red) or from the same line (blue). The sample sizes for each group (number of differentiations) are as follows: day 25: control lines, n = 46; 15q13.3del, n = 7; 16p11.2del, n = 5; 16p11.2dup, n = 4; 22q11.2del, n = 13; 22q13.3del, n = 11; idiopathic, n = 12; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 3. Day 50: control lines, n = 53; 15q13.3del, n = 7; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 15; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19 , n = 2; SHANK3, n = 2; and Timothy syndrome, n = 3. Day 75: control lines, n = 54; 15q13.3del, n = 7; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 23; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 2. Day 100: control lines, n = 50; 15q13.3del, n = 6; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 15; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 2. Boxplots show: centre, median; lower hinge, 25% quantile; upper hinge, 75% quantile; lower whisker, smallest observation greater than or equal to lower hinge −1.5× interquartile range; upper whisker, largest observation less than or equal to upper hinge +1.5× interquartile range. d , Genes within the CNVs are downregulated in deletions and upregulated in duplications, as exemplified by 16p11.2 deletion (del) and duplication (dup) and 15q13.3 deletion. 16p11.2del, 61.5% of genes; 16p11.2dup, 50% of genes and 15q13.3del, 52.9% of genes. *dreamlet P values of less than 0.005. Top illustration adapted from ref. , Springer Nature America; illustrations in the IP–MS and CRISPRi panels created in BioRender. Geschwind, D. (2025) ( https://biorender.com/m2jkj03 ).
    Figure Legend Snippet: a , Schematic workflow going from hiPS cells to cortical organoids to sequencing data. The number of hiPS cell lines and individuals (in parentheses) for each form of ASD and controls is indicated. b , Schematic representation of hCO differentiations derived from each hiPS cell line for two forms of ASD (16p11.2 deletion and 22q13.3 deletion). The other forms of ASD can be found in Extended Data Fig. . c , Spearman’s correlation of gene expression between samples from the same time point and form of ASD that were derived either from different lines (red) or from the same line (blue). The sample sizes for each group (number of differentiations) are as follows: day 25: control lines, n = 46; 15q13.3del, n = 7; 16p11.2del, n = 5; 16p11.2dup, n = 4; 22q11.2del, n = 13; 22q13.3del, n = 11; idiopathic, n = 12; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 3. Day 50: control lines, n = 53; 15q13.3del, n = 7; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 15; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19 , n = 2; SHANK3, n = 2; and Timothy syndrome, n = 3. Day 75: control lines, n = 54; 15q13.3del, n = 7; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 23; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 2. Day 100: control lines, n = 50; 15q13.3del, n = 6; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 15; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 2. Boxplots show: centre, median; lower hinge, 25% quantile; upper hinge, 75% quantile; lower whisker, smallest observation greater than or equal to lower hinge −1.5× interquartile range; upper whisker, largest observation less than or equal to upper hinge +1.5× interquartile range. d , Genes within the CNVs are downregulated in deletions and upregulated in duplications, as exemplified by 16p11.2 deletion (del) and duplication (dup) and 15q13.3 deletion. 16p11.2del, 61.5% of genes; 16p11.2dup, 50% of genes and 15q13.3del, 52.9% of genes. *dreamlet P values of less than 0.005. Top illustration adapted from ref. , Springer Nature America; illustrations in the IP–MS and CRISPRi panels created in BioRender. Geschwind, D. (2025) ( https://biorender.com/m2jkj03 ).

    Techniques Used: Sequencing, Derivative Assay, Gene Expression, Control, Whisker Assay, Protein-Protein interactions

    Whole genome sequencing depth in ( a ) 16p11.2 ( b ) 15q13.3 ( c ) 22q11.2 and ( d ) 22q13.3 loci averaged over 10 kb windows. ( e ) Mutational forms not shown in main figure showing genes inside the CNV locus or genes carrying the point mutations (marked in blue). Genes significantly differentially expressed over all time points are denoted by asterisks (dreamlet p-values of p < 0.005). The percent of DE genes in the CNV across the 4 time points is as follows: 22q13del - 77.3% of genes, 22q11del - 88.9% of genes.
    Figure Legend Snippet: Whole genome sequencing depth in ( a ) 16p11.2 ( b ) 15q13.3 ( c ) 22q11.2 and ( d ) 22q13.3 loci averaged over 10 kb windows. ( e ) Mutational forms not shown in main figure showing genes inside the CNV locus or genes carrying the point mutations (marked in blue). Genes significantly differentially expressed over all time points are denoted by asterisks (dreamlet p-values of p < 0.005). The percent of DE genes in the CNV across the 4 time points is as follows: 22q13del - 77.3% of genes, 22q11del - 88.9% of genes.

    Techniques Used: Sequencing

    ( a ) Overlaps between differentially expressed genes at all time points and risk genes for ASD from either SFARI or from large scale whole exome (WES) sequencing studies , as well as with neurodevelopmental disorders (NDDs) and intellectual disability (ID) risk genes . Colour represents the OR (two-sided Fishers exact test) and the size of the point represented the -log 10 FDR. Only positive significant overlaps (OR > 1 and FDR < 0.05) are shown. ( b ) Select gene ontology (GO) terms enriched in upregulated (red) or downregulated (blue) genes in each of the ASD forms at day 25 (top) or day 100 (bottom). Statistics derived from GSEA. ( c ) Distribution of normalized expression for meta analysis significant example genes at day 100. Boxplots show: centre, median, lower hinge – 25% quantile, upper hinge – 75% quantile, lower whisker – smallest observation greater than or equal to lower hinge –1.5× interquartile range, upper whisker – largest observation less than or equal to upper hinge +1.5× interquartile range. Number of samples (differentiations) for each form: Control – 50, 15q13.3del – 6, 16p11.2del – 6, 16p11.2dup – 4, 22q11.2del – 15, 22q13.3del – 12, Idiopathic – 15, PCDH19 – 2, SHANK3 – 2, Timothy Syndrome – 2. Asterisks denote dreamlet derived p-values: +p < 0.005,* FDR < 0.05, ** FDR < 0.01, *** FDR < 0.005. ( d ) Select GO terms enriched in upregulated or downregulated meta-analysis significant genes Colour corresponds to normalized enrichment score (NES). Point size corresponds to the level of significance (−log 10 (FDR)). Statistics derived from GSEA.
    Figure Legend Snippet: ( a ) Overlaps between differentially expressed genes at all time points and risk genes for ASD from either SFARI or from large scale whole exome (WES) sequencing studies , as well as with neurodevelopmental disorders (NDDs) and intellectual disability (ID) risk genes . Colour represents the OR (two-sided Fishers exact test) and the size of the point represented the -log 10 FDR. Only positive significant overlaps (OR > 1 and FDR < 0.05) are shown. ( b ) Select gene ontology (GO) terms enriched in upregulated (red) or downregulated (blue) genes in each of the ASD forms at day 25 (top) or day 100 (bottom). Statistics derived from GSEA. ( c ) Distribution of normalized expression for meta analysis significant example genes at day 100. Boxplots show: centre, median, lower hinge – 25% quantile, upper hinge – 75% quantile, lower whisker – smallest observation greater than or equal to lower hinge –1.5× interquartile range, upper whisker – largest observation less than or equal to upper hinge +1.5× interquartile range. Number of samples (differentiations) for each form: Control – 50, 15q13.3del – 6, 16p11.2del – 6, 16p11.2dup – 4, 22q11.2del – 15, 22q13.3del – 12, Idiopathic – 15, PCDH19 – 2, SHANK3 – 2, Timothy Syndrome – 2. Asterisks denote dreamlet derived p-values: +p < 0.005,* FDR < 0.05, ** FDR < 0.01, *** FDR < 0.005. ( d ) Select GO terms enriched in upregulated or downregulated meta-analysis significant genes Colour corresponds to normalized enrichment score (NES). Point size corresponds to the level of significance (−log 10 (FDR)). Statistics derived from GSEA.

    Techniques Used: Sequencing, Derivative Assay, Expressing, Whisker Assay, Control

    ( a ) Schema of CROP-Seq vector. ( b ) Example of gating for flow cytometry. Left shows a set of hNPCs not expressing virus used for gating compared with hNPCs expressing both dCas9-Krab (GFP) and Crop-Seq-opti-dsRed (TdTomato). Box in the upper right shows double positive cells selected for downstream analysis (~20% of live cell fraction). ( c ) QC measures for CRISPRi single cell libraries organized by gRNA negative (no gRNA detected in sequencing), Control gRNA positive, or Target gRNA positive. ( d ) Number of gRNA UMIs per cell. X-axis shows cut-off of 10 UMIs used to consider a cell gRNA positive (left). Number of of unique gRNAs expressed in each cell (x-axis). Only cells expressing gRNA for a single gene-target are retained for downstream analyses. ( e ) Single cell UMAPs of markers used to differentiate cycling and non-cyling NPCs ( f ) Single cell UMAP coloured by Target-gene presence ( g ) Proportion of cells uniquely expressing gRNAs barcodes for each target within each experiment (n = 18 per Gene comprised of 6 technical replicates, 3 gRNAs barcodes per target, for Controls n = 108: 18 gRNAs across 6 technical replicates). TP53 show increased proportion compared to non-targeting controls (NTCs). Boxplots a-c show: centre, median, lower hinge – 25% quantile, upper hinge – 75% quantile, lower whisker – smallest observation greater than or equal to lower hinge –1.5× interquartile range, upper whisker – largest observation less than or equal to upper hinge +1.5× interquartile range. ***Family wise corrected p < 0.005, Dunnets post-hoc contrast of linear model.
    Figure Legend Snippet: ( a ) Schema of CROP-Seq vector. ( b ) Example of gating for flow cytometry. Left shows a set of hNPCs not expressing virus used for gating compared with hNPCs expressing both dCas9-Krab (GFP) and Crop-Seq-opti-dsRed (TdTomato). Box in the upper right shows double positive cells selected for downstream analysis (~20% of live cell fraction). ( c ) QC measures for CRISPRi single cell libraries organized by gRNA negative (no gRNA detected in sequencing), Control gRNA positive, or Target gRNA positive. ( d ) Number of gRNA UMIs per cell. X-axis shows cut-off of 10 UMIs used to consider a cell gRNA positive (left). Number of of unique gRNAs expressed in each cell (x-axis). Only cells expressing gRNA for a single gene-target are retained for downstream analyses. ( e ) Single cell UMAPs of markers used to differentiate cycling and non-cyling NPCs ( f ) Single cell UMAP coloured by Target-gene presence ( g ) Proportion of cells uniquely expressing gRNAs barcodes for each target within each experiment (n = 18 per Gene comprised of 6 technical replicates, 3 gRNAs barcodes per target, for Controls n = 108: 18 gRNAs across 6 technical replicates). TP53 show increased proportion compared to non-targeting controls (NTCs). Boxplots a-c show: centre, median, lower hinge – 25% quantile, upper hinge – 75% quantile, lower whisker – smallest observation greater than or equal to lower hinge –1.5× interquartile range, upper whisker – largest observation less than or equal to upper hinge +1.5× interquartile range. ***Family wise corrected p < 0.005, Dunnets post-hoc contrast of linear model.

    Techniques Used: Plasmid Preparation, Flow Cytometry, Expressing, Virus, Single Cell, Sequencing, Control, Whisker Assay



    Similar Products

    96
    Broad Clinical Labs picard sequencing metrics
    a , Schematic workflow going from hiPS cells to cortical organoids to <t>sequencing</t> data. The number of hiPS cell lines and individuals (in parentheses) for each form of ASD and controls is indicated. b , Schematic representation of hCO differentiations derived from each hiPS cell line for two forms of ASD (16p11.2 deletion and 22q13.3 deletion). The other forms of ASD can be found in Extended Data Fig. . c , Spearman’s correlation of gene expression between samples from the same time point and form of ASD that were derived either from different lines (red) or from the same line (blue). The sample sizes for each group (number of differentiations) are as follows: day 25: control lines, n = 46; 15q13.3del, n = 7; 16p11.2del, n = 5; 16p11.2dup, n = 4; 22q11.2del, n = 13; 22q13.3del, n = 11; idiopathic, n = 12; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 3. Day 50: control lines, n = 53; 15q13.3del, n = 7; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 15; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19 , n = 2; SHANK3, n = 2; and Timothy syndrome, n = 3. Day 75: control lines, n = 54; 15q13.3del, n = 7; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 23; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 2. Day 100: control lines, n = 50; 15q13.3del, n = 6; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 15; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 2. Boxplots show: centre, median; lower hinge, 25% quantile; upper hinge, 75% quantile; lower whisker, smallest observation greater than or equal to lower hinge −1.5× interquartile range; upper whisker, largest observation less than or equal to upper hinge +1.5× interquartile range. d , Genes within the CNVs are downregulated in deletions and upregulated in duplications, as exemplified by 16p11.2 deletion (del) and duplication (dup) and 15q13.3 deletion. 16p11.2del, 61.5% of genes; 16p11.2dup, 50% of genes and 15q13.3del, 52.9% of genes. *dreamlet P values of less than 0.005. Top illustration adapted from ref. , Springer Nature America; illustrations in the IP–MS and CRISPRi panels created in BioRender. Geschwind, D. (2025) ( https://biorender.com/m2jkj03 ).
    Picard Sequencing Metrics, supplied by Broad Clinical Labs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/picard sequencing metrics/product/Broad Clinical Labs
    Average 96 stars, based on 1 article reviews
    picard sequencing metrics - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    90
    Sentieon Inc picard sequencing metrics

    Picard Sequencing Metrics, supplied by Sentieon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/picard sequencing metrics/product/Sentieon Inc
    Average 90 stars, based on 1 article reviews
    picard sequencing metrics - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    a , Schematic workflow going from hiPS cells to cortical organoids to sequencing data. The number of hiPS cell lines and individuals (in parentheses) for each form of ASD and controls is indicated. b , Schematic representation of hCO differentiations derived from each hiPS cell line for two forms of ASD (16p11.2 deletion and 22q13.3 deletion). The other forms of ASD can be found in Extended Data Fig. . c , Spearman’s correlation of gene expression between samples from the same time point and form of ASD that were derived either from different lines (red) or from the same line (blue). The sample sizes for each group (number of differentiations) are as follows: day 25: control lines, n = 46; 15q13.3del, n = 7; 16p11.2del, n = 5; 16p11.2dup, n = 4; 22q11.2del, n = 13; 22q13.3del, n = 11; idiopathic, n = 12; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 3. Day 50: control lines, n = 53; 15q13.3del, n = 7; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 15; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19 , n = 2; SHANK3, n = 2; and Timothy syndrome, n = 3. Day 75: control lines, n = 54; 15q13.3del, n = 7; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 23; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 2. Day 100: control lines, n = 50; 15q13.3del, n = 6; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 15; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 2. Boxplots show: centre, median; lower hinge, 25% quantile; upper hinge, 75% quantile; lower whisker, smallest observation greater than or equal to lower hinge −1.5× interquartile range; upper whisker, largest observation less than or equal to upper hinge +1.5× interquartile range. d , Genes within the CNVs are downregulated in deletions and upregulated in duplications, as exemplified by 16p11.2 deletion (del) and duplication (dup) and 15q13.3 deletion. 16p11.2del, 61.5% of genes; 16p11.2dup, 50% of genes and 15q13.3del, 52.9% of genes. *dreamlet P values of less than 0.005. Top illustration adapted from ref. , Springer Nature America; illustrations in the IP–MS and CRISPRi panels created in BioRender. Geschwind, D. (2025) ( https://biorender.com/m2jkj03 ).

    Journal: Nature

    Article Title: Developmental convergence and divergence in human stem cell models of autism

    doi: 10.1038/s41586-025-10047-5

    Figure Lengend Snippet: a , Schematic workflow going from hiPS cells to cortical organoids to sequencing data. The number of hiPS cell lines and individuals (in parentheses) for each form of ASD and controls is indicated. b , Schematic representation of hCO differentiations derived from each hiPS cell line for two forms of ASD (16p11.2 deletion and 22q13.3 deletion). The other forms of ASD can be found in Extended Data Fig. . c , Spearman’s correlation of gene expression between samples from the same time point and form of ASD that were derived either from different lines (red) or from the same line (blue). The sample sizes for each group (number of differentiations) are as follows: day 25: control lines, n = 46; 15q13.3del, n = 7; 16p11.2del, n = 5; 16p11.2dup, n = 4; 22q11.2del, n = 13; 22q13.3del, n = 11; idiopathic, n = 12; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 3. Day 50: control lines, n = 53; 15q13.3del, n = 7; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 15; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19 , n = 2; SHANK3, n = 2; and Timothy syndrome, n = 3. Day 75: control lines, n = 54; 15q13.3del, n = 7; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 23; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 2. Day 100: control lines, n = 50; 15q13.3del, n = 6; 16p11.2del, n = 6; 16p11.2dup, n = 4; 22q11.2del, n = 15; 22q13.3del, n = 12; idiopathic, n = 15; PCDH19, n = 2; SHANK3, n = 2; and Timothy syndrome, n = 2. Boxplots show: centre, median; lower hinge, 25% quantile; upper hinge, 75% quantile; lower whisker, smallest observation greater than or equal to lower hinge −1.5× interquartile range; upper whisker, largest observation less than or equal to upper hinge +1.5× interquartile range. d , Genes within the CNVs are downregulated in deletions and upregulated in duplications, as exemplified by 16p11.2 deletion (del) and duplication (dup) and 15q13.3 deletion. 16p11.2del, 61.5% of genes; 16p11.2dup, 50% of genes and 15q13.3del, 52.9% of genes. *dreamlet P values of less than 0.005. Top illustration adapted from ref. , Springer Nature America; illustrations in the IP–MS and CRISPRi panels created in BioRender. Geschwind, D. (2025) ( https://biorender.com/m2jkj03 ).

    Article Snippet: To control for technical variation due to the sequencing and library prep we calculated the principal components of the Picard sequencing metrics ( http://broadinstitute.github.io/picard/ ) using the CollectAlignmentSummaryMetrics, CollectRnaSeqMetrics and MarkDuplicates modules, and included them in our model. To infer genetic ancestry, we called single-nucleotide polymorphisms (SNPs) from the aligned reads using the GATK (v.3.3) Haplotype caller .

    Techniques: Sequencing, Derivative Assay, Gene Expression, Control, Whisker Assay, Protein-Protein interactions

    Whole genome sequencing depth in ( a ) 16p11.2 ( b ) 15q13.3 ( c ) 22q11.2 and ( d ) 22q13.3 loci averaged over 10 kb windows. ( e ) Mutational forms not shown in main figure showing genes inside the CNV locus or genes carrying the point mutations (marked in blue). Genes significantly differentially expressed over all time points are denoted by asterisks (dreamlet p-values of p < 0.005). The percent of DE genes in the CNV across the 4 time points is as follows: 22q13del - 77.3% of genes, 22q11del - 88.9% of genes.

    Journal: Nature

    Article Title: Developmental convergence and divergence in human stem cell models of autism

    doi: 10.1038/s41586-025-10047-5

    Figure Lengend Snippet: Whole genome sequencing depth in ( a ) 16p11.2 ( b ) 15q13.3 ( c ) 22q11.2 and ( d ) 22q13.3 loci averaged over 10 kb windows. ( e ) Mutational forms not shown in main figure showing genes inside the CNV locus or genes carrying the point mutations (marked in blue). Genes significantly differentially expressed over all time points are denoted by asterisks (dreamlet p-values of p < 0.005). The percent of DE genes in the CNV across the 4 time points is as follows: 22q13del - 77.3% of genes, 22q11del - 88.9% of genes.

    Article Snippet: To control for technical variation due to the sequencing and library prep we calculated the principal components of the Picard sequencing metrics ( http://broadinstitute.github.io/picard/ ) using the CollectAlignmentSummaryMetrics, CollectRnaSeqMetrics and MarkDuplicates modules, and included them in our model. To infer genetic ancestry, we called single-nucleotide polymorphisms (SNPs) from the aligned reads using the GATK (v.3.3) Haplotype caller .

    Techniques: Sequencing

    ( a ) Overlaps between differentially expressed genes at all time points and risk genes for ASD from either SFARI or from large scale whole exome (WES) sequencing studies , as well as with neurodevelopmental disorders (NDDs) and intellectual disability (ID) risk genes . Colour represents the OR (two-sided Fishers exact test) and the size of the point represented the -log 10 FDR. Only positive significant overlaps (OR > 1 and FDR < 0.05) are shown. ( b ) Select gene ontology (GO) terms enriched in upregulated (red) or downregulated (blue) genes in each of the ASD forms at day 25 (top) or day 100 (bottom). Statistics derived from GSEA. ( c ) Distribution of normalized expression for meta analysis significant example genes at day 100. Boxplots show: centre, median, lower hinge – 25% quantile, upper hinge – 75% quantile, lower whisker – smallest observation greater than or equal to lower hinge –1.5× interquartile range, upper whisker – largest observation less than or equal to upper hinge +1.5× interquartile range. Number of samples (differentiations) for each form: Control – 50, 15q13.3del – 6, 16p11.2del – 6, 16p11.2dup – 4, 22q11.2del – 15, 22q13.3del – 12, Idiopathic – 15, PCDH19 – 2, SHANK3 – 2, Timothy Syndrome – 2. Asterisks denote dreamlet derived p-values: +p < 0.005,* FDR < 0.05, ** FDR < 0.01, *** FDR < 0.005. ( d ) Select GO terms enriched in upregulated or downregulated meta-analysis significant genes Colour corresponds to normalized enrichment score (NES). Point size corresponds to the level of significance (−log 10 (FDR)). Statistics derived from GSEA.

    Journal: Nature

    Article Title: Developmental convergence and divergence in human stem cell models of autism

    doi: 10.1038/s41586-025-10047-5

    Figure Lengend Snippet: ( a ) Overlaps between differentially expressed genes at all time points and risk genes for ASD from either SFARI or from large scale whole exome (WES) sequencing studies , as well as with neurodevelopmental disorders (NDDs) and intellectual disability (ID) risk genes . Colour represents the OR (two-sided Fishers exact test) and the size of the point represented the -log 10 FDR. Only positive significant overlaps (OR > 1 and FDR < 0.05) are shown. ( b ) Select gene ontology (GO) terms enriched in upregulated (red) or downregulated (blue) genes in each of the ASD forms at day 25 (top) or day 100 (bottom). Statistics derived from GSEA. ( c ) Distribution of normalized expression for meta analysis significant example genes at day 100. Boxplots show: centre, median, lower hinge – 25% quantile, upper hinge – 75% quantile, lower whisker – smallest observation greater than or equal to lower hinge –1.5× interquartile range, upper whisker – largest observation less than or equal to upper hinge +1.5× interquartile range. Number of samples (differentiations) for each form: Control – 50, 15q13.3del – 6, 16p11.2del – 6, 16p11.2dup – 4, 22q11.2del – 15, 22q13.3del – 12, Idiopathic – 15, PCDH19 – 2, SHANK3 – 2, Timothy Syndrome – 2. Asterisks denote dreamlet derived p-values: +p < 0.005,* FDR < 0.05, ** FDR < 0.01, *** FDR < 0.005. ( d ) Select GO terms enriched in upregulated or downregulated meta-analysis significant genes Colour corresponds to normalized enrichment score (NES). Point size corresponds to the level of significance (−log 10 (FDR)). Statistics derived from GSEA.

    Article Snippet: To control for technical variation due to the sequencing and library prep we calculated the principal components of the Picard sequencing metrics ( http://broadinstitute.github.io/picard/ ) using the CollectAlignmentSummaryMetrics, CollectRnaSeqMetrics and MarkDuplicates modules, and included them in our model. To infer genetic ancestry, we called single-nucleotide polymorphisms (SNPs) from the aligned reads using the GATK (v.3.3) Haplotype caller .

    Techniques: Sequencing, Derivative Assay, Expressing, Whisker Assay, Control

    ( a ) Schema of CROP-Seq vector. ( b ) Example of gating for flow cytometry. Left shows a set of hNPCs not expressing virus used for gating compared with hNPCs expressing both dCas9-Krab (GFP) and Crop-Seq-opti-dsRed (TdTomato). Box in the upper right shows double positive cells selected for downstream analysis (~20% of live cell fraction). ( c ) QC measures for CRISPRi single cell libraries organized by gRNA negative (no gRNA detected in sequencing), Control gRNA positive, or Target gRNA positive. ( d ) Number of gRNA UMIs per cell. X-axis shows cut-off of 10 UMIs used to consider a cell gRNA positive (left). Number of of unique gRNAs expressed in each cell (x-axis). Only cells expressing gRNA for a single gene-target are retained for downstream analyses. ( e ) Single cell UMAPs of markers used to differentiate cycling and non-cyling NPCs ( f ) Single cell UMAP coloured by Target-gene presence ( g ) Proportion of cells uniquely expressing gRNAs barcodes for each target within each experiment (n = 18 per Gene comprised of 6 technical replicates, 3 gRNAs barcodes per target, for Controls n = 108: 18 gRNAs across 6 technical replicates). TP53 show increased proportion compared to non-targeting controls (NTCs). Boxplots a-c show: centre, median, lower hinge – 25% quantile, upper hinge – 75% quantile, lower whisker – smallest observation greater than or equal to lower hinge –1.5× interquartile range, upper whisker – largest observation less than or equal to upper hinge +1.5× interquartile range. ***Family wise corrected p < 0.005, Dunnets post-hoc contrast of linear model.

    Journal: Nature

    Article Title: Developmental convergence and divergence in human stem cell models of autism

    doi: 10.1038/s41586-025-10047-5

    Figure Lengend Snippet: ( a ) Schema of CROP-Seq vector. ( b ) Example of gating for flow cytometry. Left shows a set of hNPCs not expressing virus used for gating compared with hNPCs expressing both dCas9-Krab (GFP) and Crop-Seq-opti-dsRed (TdTomato). Box in the upper right shows double positive cells selected for downstream analysis (~20% of live cell fraction). ( c ) QC measures for CRISPRi single cell libraries organized by gRNA negative (no gRNA detected in sequencing), Control gRNA positive, or Target gRNA positive. ( d ) Number of gRNA UMIs per cell. X-axis shows cut-off of 10 UMIs used to consider a cell gRNA positive (left). Number of of unique gRNAs expressed in each cell (x-axis). Only cells expressing gRNA for a single gene-target are retained for downstream analyses. ( e ) Single cell UMAPs of markers used to differentiate cycling and non-cyling NPCs ( f ) Single cell UMAP coloured by Target-gene presence ( g ) Proportion of cells uniquely expressing gRNAs barcodes for each target within each experiment (n = 18 per Gene comprised of 6 technical replicates, 3 gRNAs barcodes per target, for Controls n = 108: 18 gRNAs across 6 technical replicates). TP53 show increased proportion compared to non-targeting controls (NTCs). Boxplots a-c show: centre, median, lower hinge – 25% quantile, upper hinge – 75% quantile, lower whisker – smallest observation greater than or equal to lower hinge –1.5× interquartile range, upper whisker – largest observation less than or equal to upper hinge +1.5× interquartile range. ***Family wise corrected p < 0.005, Dunnets post-hoc contrast of linear model.

    Article Snippet: To control for technical variation due to the sequencing and library prep we calculated the principal components of the Picard sequencing metrics ( http://broadinstitute.github.io/picard/ ) using the CollectAlignmentSummaryMetrics, CollectRnaSeqMetrics and MarkDuplicates modules, and included them in our model. To infer genetic ancestry, we called single-nucleotide polymorphisms (SNPs) from the aligned reads using the GATK (v.3.3) Haplotype caller .

    Techniques: Plasmid Preparation, Flow Cytometry, Expressing, Virus, Single Cell, Sequencing, Control, Whisker Assay

    Journal: medRxiv

    Article Title: Long-read genome sequencing and variant reanalysis increase diagnostic yield in neurodevelopmental disorders

    doi: 10.1101/2024.03.22.24304633

    Figure Lengend Snippet:

    Article Snippet: Sequencing metrics were generated from the aligned BAMs using the Sentieon implementations of Picard sequencing metrics ( ).

    Techniques: Sequencing